10 May 2017 - MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has welcomed the Australian Government’s 2017 Budget, set to provide positive outcomes for the support and growth of innovation in the Australian MTP sector.

The budget is well positioned to provide major new investments in manufacturing industries and cutting edge research infrastructure, as well as strengthening Medicare and providing support for the Pharmaceutical Benefits Scheme (PBS), hospitals, increasing mental and preventative health measures, and welcome investment into clinical trials and medical research.

These investments are set to provide a welcome boost to the MTP industry in Australia, assist with advanced manufacturing capacities, and leverage Australia’s unique advantages as an international destination for clinical trials to provide economic benefits not only to the sector but the Australian economy.

Read MTP Connect press release